Acute Myeloid leukemia:
Patients are treated according to modified St. Jude AML 02 protocol9, we propose the following recommendations:
  1. Induction chemotherapy: Omit etoposide so induction consists of Ara-C and Doxorubicin based on Medical research council AML 15 clinical trial10.
  2. The use of G-CSF during induction chemotherapy 24 hours after chemotherapy and 48 hours before the next cycle of chemotherapy if BMA at D15 less than 5%.